Skip to content

Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02781532
Enrollment
100
Registered
2016-05-24
Start date
2014-04-30
Completion date
2015-01-31
Last updated
2016-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Neoplasms

Brief summary

The main objective of our study is to determine if the evaluation of ingesta of cancer patients by VAS (on the day of hospitalization) is able to predict the actual ingesta of patients during hospitalization (for patients malnourished, at risk of malnutrition or risk free).

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged over 18 years * Admitted to hospital for systemic therapy of gastrointestinal cancer * Signature of the non-opposition.

Exclusion criteria

* Patients who because of their affection will fasted more than 12:00 during the three days preceding hospitalization. * Artificial nutrition Patients

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of ingesta3 daysEvaluation of ingesta will be done using SAV scale.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026